Predictive ADMET, London, UK

Over 50% of drug development failures are due to ADME and toxicity. With statistics like these, pharmaceutical companies are striving to find fast and accurate models to predict these properties earlier in discovery. Predictive ADME-Tox will reveal the latest computational and experimental tools that are being successfully applied in industry to reduce the crippling costs caused by these failures.